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Following axotomy, the activation of multiple intracellular signaling cascades causes the
expression of a cocktail of regeneration-associated transcription factors which interact with
each other to determine the fate of the injured neurons.The nerve injury response is chan-
neled through manifold and parallel pathways, integrating diverse inputs, and controlling a
complex transcriptional output.Transcription factors form a vital link in the chain of regener-
ation, converting injury-induced stress signals into downstreamprotein expression via gene
regulation. They can regulate the intrinsic ability of axons to grow, by controlling expres-
sion of whole cassettes of gene targets. In this review, we have investigated the functional
roles of a number of different transcription factors – c-Jun, activating transcription factor 3,
cAMP response element binding protein, signal transducer, and activator of transcription-3,
CCAAT/enhancer binding proteins β and δ, Oct-6, Sox11, p53, nuclear factor kappa-light-
chain-enhancer of activated B cell, and ELK3 – in peripheral nerve regeneration. Studies
involving use of conditional mutants, microarrays, promoter region mapping, and different
injury paradigms, have enabled us to understand their distinct as well as overlapping roles
in achieving anatomical and functional regeneration after peripheral nerve injury.
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INTRODUCTION
Injury to peripheral nerves elicits a sequence of molecular, cel-
lular, and ultrastructural responses which are vital in triggering
a successful regenerative program associated with neurite out-
growth, re-innervation of the denervated target and recovery of
function. The rapid arrival of signals from the injured axon results
in a remarkable shift of the injured neuron from a transmit-
ting to a growth promoting phenotype. This is accomplished by
the upregulation of a vast array of regeneration-associated genes
(RAGs) including the rapid induction of transcription factors and
enhanced synthesis of adhesion molecules, cytoskeletal elements,
growth factors, cytokines, neuropeptides, and other molecules
involved in regeneration.
The molecular changes are accompanied by pronounced mor-
phological changes in the surviving neurons – the cell body under-
goes a “chromatolytic” reaction characterized by swelling of the
neuronal body, increase in cellular metabolism and protein syn-
thesis, and a regional dispersion of Nissl bodies in the neuronal
cytoplasm (Lieberman, 1971); and there is a rapid appearance
of growth cones at the proximal tip of the lesioned axons. The
distal nerve stump undergoes “Wallerian degeneration” (Waller,
1850;Dubový, 2011), leading to phagocytosis of axonal andmyelin
debris by Schwann cells and later also by invading macrophages.
In addition to the neuronal response, neighboring non-
neuronal glial cells – in the case of brain and spinal cord
motoneurons, the astrocytes, and microglia – become activated,
with microglial expression of immune cell recognition molecules
(ICAM1, aMb2, and aXb2 integrins, B7 system, etc.) and major
histocompatibility complex (Werner et al., 1998; Bohatschek et al.,
2004). There is also a rapid microglia-associated recruitment of
lymphocytes within a day after injury which may assist with
immune surveillance ﬁrst in the absence, and later on in the pres-
ence of neuronal cell death (Raivich et al., 1998; Kalla et al., 2001).
In the adult mouse facial motor nucleus model which has been
studied in extensive detail, neuronal cell death is a delayed phe-
nomenon, peaking at 2 weeks following nerve transection; the
glioimmune activation is characterized by two phases – a fast
but moderate response starting within 24 h after neuronal injury,
and a late but much stronger response to neuronal cell death,
peaking at 14 days after axotomy. Neuronal transcription factor
deletions blocking cell death will suppress most of the late glioim-
mune response (Raivich et al., 2004; Patodia et al., 2011). However,
these deletions also inhibit some of the early microglial activa-
tion – within 24 h and long before the appearance of cell death,
suggesting that these transcription factors may also interfere with
the synthesis of injury signals from lesionedbut not dyingneurons.
In contrast with the PNS, the CNS neurons normally fail to
regenerate after injury, possibly due to a combination of dimin-
ished intrinsic capacity for regeneration and a heightened sus-
ceptibility to increased inhibitory factors of their extracellular
environment (Maier and Schwab, 2006; Sun et al., 2011). Identi-
fying the crucial elements responsible for successful regeneration
in injured peripheral nerves, and unraveling their underlying sig-
naling pathways and molecular components will be quintessential
in improving regenerative outcomes after peripheral and central
nerve injuries.
Systematic gene expression proﬁling using cDNA microarrays
has led to a dramatic increase in the number of identiﬁed genes
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regulated in the injured and regenerating neurons (Bosse et al.,
2001, 2006; Costigan et al., 2002; Kubo et al., 2002; Boeshore et al.,
2004; Kury et al., 2004; Michaelevski et al., 2010). Interestingly,
roughly half of the RAGs are part of both developmental and
lesion-induced programs, suggesting that regeneration partially
recapitulates development. However, this proportion of shared
developmental and lesion-induced transcripts was substantially
lower – only 33% – for genes encoding signal transducers or fac-
tors involved in processes such as cell death, immune response,
transport, and transcriptional regulation. Most of the latter show
injury-speciﬁc gene expression (Bosse et al., 2006).
Transcription factors are DNA binding proteins that can acti-
vate or repress target gene expression. Their effects are ampliﬁed by
their ability to bind to multiple promoter regions, causing a large
number of genes to be switched on or off by a single transcription
factor. In this review,wewill be discussing the keymolecular events
ensuing peripheral nerve injury, focusing on various transcrip-
tion factors that have been implicated to play a role in neuronal
regeneration.
EARLY AXONAL INJURY SENSORS
Axonal injury generates three major signaling cues to the injured
neurons:
A. It interferes with the retrograde ﬂow of trophic signals, disin-
hibiting the normally suppressed regenerative process, within
12–24 h following injury (Raivich et al., 1991).
B. It exposes the tip of the injured axons to the intracellular
content of neighboring axons and Schwann cells containing
growth factors like LIF, CNTF, FGF, and NT3 (Elde et al., 1991;
Sendtner et al., 1997; Kirsch et al., 2003), and later to the
inﬂamed neural tissue environment (Lindholm et al., 1987).
The above two processes can result in de novo activated mole-
cules carrying a nuclear localization sequence (NLS)which link
to importins and are retrogradely transported to the cell body
by dynein motors (Schmied et al., 1993; Hanz et al., 2003).
C. It causes a disruption of the tight ionic concentration gradient
between the axon and the extracellular matrix by rapid inﬂux
of extracellular ions such as calcium and sodium through the
transiently open plasmalemma before it is resealed (Yoo et al.,
2003). This results in depolarization and transmission of suc-
cessive injury-mediated action potentials. Thesemolecular and
electrical signals cause rapid elevation of calcium and cAMP,
which in turn activate multiple downstream pathways (Berdan
et al., 1993).
TRANSCRIPTIONAL CHANGES
The arrival of injury signals is rapidly followed by the phos-
phorylation and nuclear localization of a host of transcrip-
tion factors. A brief summary of signaling from early sen-
sors to mostly enzymatic cytoplasmic mediators to transcrip-
tion factors and synthesis of effector molecules is shown in
Figure 1. Data from phospho-proteomic and microarray studies
FIGURE 1 | Cellular signaling in successful regeneration, from early sensors of injury, to cytoplasmic signals, transcription, and downstream effectors
(Modified Raivich, 2011).
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have identiﬁed nearly 400 redundant axonal signaling networks
connected to 39 transcription factors (26 transcription factor fam-
ilies), implicated in the sensory neuron response to axonal injury
(Michaelevski et al., 2010). These include c-Jun, Jun D, activating
transcription factor 3 (ATF3), cAMP response element binding
protein (CREB), signal transducer and activator of transcription
(STAT3), CCAAT/enhancer binding proteins (C/EBPs), p53, Oct-
6, nuclear factor kappa-light-chain-enhancer of activated B cells
(NF-κB), nuclear factor of activated T-cells (NFATs), Kruppel-
like factors (KLFs), Sox11, SnoN, ELK3, P311, and E47 among
others (Schwaiger et al., 2000; Mason et al., 2003; Raivich et al.,
2004; Nadeau et al., 2005; Di Giovanni et al., 2006; Jankowski
et al., 2009; Ruff et al., 2009; Magoulas and Lopez-de Heredia,
2010; Moore and Goldberg, 2011; Raivich, 2011). Once in the
nucleus, they bind to selective DNA promoter regions to increase
or repress transcription of speciﬁc target genes. Nerve injury can
also result in reduced activation of transcription factors such as
islet-1, Fra-2, ATF2, and TDP43 (Doyle and Hunt, 1997; Herde-
gen et al., 1997a; Hol et al., 1999; Moisse et al., 2009; Sato et al.,
2009), which probably contributes to the change in gene expres-
sion of the injured neuron from a fully differentiated to a growing
phenotype (Raivich, 2011). The activation of transcriptional pro-
gram is critical for expression of many target genes implicated
in successful regeneration, and blocking of transcription at an
early time point after injury changes the regenerative response
of injured neurons (Smith and Skene, 1997). Recent advances
in cre/loxP technology permitting cell-type and/or time spe-
ciﬁc genetic knockouts (Sauer, 1998; Akira, 2000) have begun
to provide insight into the powerful roles of these transcription
factors in orchestrating complex axon growth and regenerative
responses. An overview of the observed phenotypes is given in
Table 1.
C-Jun
The AP-1 transcription complex is a well-characterized regulator
of neural development and consists of homo- or hetero-dimeric
complexes between members of the Jun, c-Fos, and ATF/CREB
families. A primary component of theAP-1 complex, c-Jun, is pro-
duced as an immediate early gene (IEG) following nerve injury and
persists at high levels in injured neurons during the entire periph-
eral regenerative process (Herdegen et al.,1991;Kenney andKocsis,
1998; Mason et al., 2003; Raivich et al., 2004; Lindwall and Kanje,
2005; Ruff et al., 2009). Schwann cells also strongly upregulate c-
Jun following axotomy, where it functions as a negative regulator
of myelination and switches on local inﬂammation (Arthur-Farraj
et al., 2007; Latouche et al., 2009; Wilton et al., 2009). Numerous
studies, using targeted gene deletions or pharmacological inhibi-
tion, have examined the activation, function, and cellular basis
Table 1 |Transcription factor deletions and peripheral nerve regeneration: effects of global (G) and cell-type specific (cts) knockouts (KO).
Transcription factor
G KO or CTS KO
KO phenotype Reference
Neuronal c-Jun (CTS) Strongly reduced target re-innervation Raivich et al. (2004), Makwana et al.
(2010), Ruff et al. (2009)Delayed functional recovery
Decreased RAG expression and neuronal sprouting
Strongly reduced glial activation and leukocyte recruitment
Enhanced motoneuron survival
Cellular atrophy
Schwann cell c-Jun (CTS) Severely impaired axonal regeneration Ruff et al. (2009)
Drastically reduced motoneuron survival
Jun 2A (G) Cellular atrophy Ruff et al. (2009)
Jun 4A (G) Moderately reduced target re-innervation and functional recovery Patodia et al. (unpublished)
Cellular atrophy
ATF3 (G) Enhanced speed of regeneration in mice constitutively expressing ATF3 in DRGs Seijffers et al. (2007)
CREB (G) Impaired axonal/neurite growth Lonze et al. (2002), Lonze and Ginty
(2002), Redmond et al. (2002)Increased apoptosis of sensory neurons
Neuronal STAT3 (CTS) Strongly reduced target re-innervation Bareyre et al. (2011), Patodia et al. (2011)
Delayed functional recovery
Decreased RAG expression and neuronal sprouting
Strongly reduced glial activation and leukocyte recruitment
Enhanced motoneuron survival
Cellular atrophy
C/EBPβ (G) Reduced expression of microtubule Tα1 α tubulin and growth cone protein GAP-43 Nadeau et al. (2005)
C/EBPδ (G) Impaired axonal growth and reduced response to conditioning lesion Magoulas and Lopez-de Heredia (2010),
Patodia et al. (unpublished)Reduced microglial activation
Sox 11 (CTS) Reduced regeneration after nerve crush Jankowski et al. (2009)
p53 (G) Growth cone collapse Di Giovanni et al. (2006), Tedeschi et al.
(2009), Qin et al. (2009)Decreased neurite outgrowth
Reduced target re-innervation
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of c-Jun and suggest a tripartite role of c-Jun action in neural
degeneration, inﬂammation, and repair (Raivich, 2008).
Nestin-cre mediated deletion of c-Jun prevented the upreg-
ulation of axotomy-associated molecules (CD44, α7β1 integrin,
galanin). It also decreased perineuronal sprouting (Makwana et al.,
2010) and successful reconnection to peripheral targets by four to
ﬁvefold, and strongly reduced functional recovery (Raivich et al.,
2004). This massive reduction in target re-innervation was also
observed more than 3months after facial nerve cut, suggesting
that it was a persistent defect, rather than just a delay in the
speed of regeneration. Incidentally, functional recovery did not
appear to require re-innervation of the target by the same num-
ber of neurons. Compared with the Jun-competent littermates,
functional recovery showed a longer but nevertheless transient
delay, suggesting that long term, target re-innervation by a fraction
of neurons could produce extensive functional recovery (Raivich
et al., 2004). Importantly, though functional recovery is clinically
the critical parameter, a sole reliance on this parameter could over-
estimate the extent of re-innervation. Non-neuronal responses
like leukocyte recruitment and microglial activation were also
severely compromised in the mutants. Interestingly, the facial
motoneurons in the mutants showed enhanced post-axotomy
survival, but were severely shrunken (Raivich et al., 2004), sup-
porting the previously reported functional dichotomy of c-Jun in
promoting post-traumatic neuronal cell death as well as axonal
regeneration (Herdegen et al., 1997b; Herdegen and Waetzig,
2001).
Because this cre Recombinase was driven by a nestin-promoter
expressed in early neuroepithelial cells giving rise to neurons,
astrocytes, or oligodendrocytes, as well as Schwann cells it is raised
the question whether the effects observed in neuronal regenera-
tion were due to the absence of c-Jun in neurons or other nestin+
progenitor-derived cells. This issue was addressed by using trans-
genic mice having neuron-speciﬁc (synapsin promoter controlled
cre-recombination) or Schwann cell-speciﬁc [myelin protein zero
(P0) promoter controlled cre-recombination] c-Jun deletions.
Neuron-speciﬁc c-Jun deletion mirrored the regeneration defect
seen with nestin-cre mediated deletion of c-Jun, i.e., strongly
reduced speed of axonal regeneration, signiﬁcantly delayed func-
tional recovery, strongly reduced target re-innervation, enhanced
motoneuron survival but cellular atrophy and diminished astro-
cyte and microglial activation and T-cell inﬂux (Ruff et al.,
2009). The absence of c-Jun in Schwann cells also caused severely
impaired axonal regeneration. However, it strongly increased neu-
ronal cell death after nerve injury (Ruff et al., 2009). These results
suggest a critical role of both Schwann cell and neuronal c-Jun
in the axonal injury response, which led to the next challenge
of understanding the mechanisms underlying its activation and
signaling following axonal injury.
Activation of c-Jun mediated transcription is affected by inter-
actions at three major sites: N-terminal phosphorylation at serines
63 and 73 and threonines 91 and 93 by the Jun N-terminal kinases
(JNKs) and the ensuing ubiquitination and degradation, dephos-
phorylation of Thr239, and C-terminal lysine acetylation near aa
257–276 (Vries et al., 2001; Morton et al., 2003). The JNKs are
rapidly activated following peripheral nerve injury, and are ret-
rogradely transported to the cell body along with the upstream
kinases MEKK1 and p-MKK4, as well as the JNK interacting pro-
tein (JIP), a scaffold protein that stabilizes the interaction between
JNKand its upstreamkinases (Lindwall andKanje,2005), reviewed
in Raivich (2008). Neuronal injury increases JNK-mediated c-Jun
phosphorylation (Herdegen et al., 1998; Kenney and Kocsis, 1998),
and application of a JNK inhibitor to explants of injured DRGs
reduces c-Jun phosphorylation, ATF3 expression, and neurite
outgrowth, without affecting survival (Lindwall et al., 2004).
Removal of Ser63 and 73 phosphoacceptor sites in the JunAA
mutant interfered with kainic acid excitotoxicity in hippocam-
pal neurons (Behrens et al., 1999) at levels similar to JNK3 KO
(Brecht et al., 2005), identifying c-Jun as an essential substrate of
JNK signaling during kainate-induced neuronal apoptosis. While
global c-Jun deletion is embryonically lethal, JunAA mice showed
normal development (albeit slightly smaller than littermate wild-
type mice) and were fertile (Behrens et al., 1999). Following optic
nerve transection, there was a partial but signiﬁcant reduction of
the apoptosis of retinal ganglion cells in JunAA mice, and Fas L
has been suggested to be an important target gene regulated by
N-terminal Jun phosphorylation during apoptosis (Yoshida et al.,
2002). JunAA and JNK3 null mutants also showed better neuronal
survival after targeted dopaminergic cell death (Brecht et al., 2005;
Crocker et al., 2006). Trophic factor deprivation or DNA damage-
induced death was signiﬁcantly delayed in JunAA neurons which
correlated with delayed expression of pro-apoptotic genes (Besirli
et al., 2005). In contrast, the JNK3 KO or JunAA mutations did
not interfere with neuronal cell death after facial axotomy (Brecht
et al., 2005; Ruff et al., 2009). This difference could be attributed
to the fact that facial axotomy affects peripheral neurons, unlike
previous studies which discuss effects of phosphorylation deﬁcient
c-Jun on apoptosis of CNS neurons.
Preliminary studies from our group after facial axotomy
revealed that JunAA mice do show some neuronal shrinkage, but
have no effect on speed of axonal regeneration for fastest axons,
functional recovery, or target re-innervation (Ruff et al., 2009).
Deletion of JNK1 or JNK3 single genes showed somewhat delayed
functional recovery after facial nerve axotomy but the effects were
quite moderate; and deletion of JNK2 had no effect on regenera-
tion (Ruff et al., 2009). The mild effects of JunAA and global JNK
deletions, and the fact that JNKs can act via c-Jun independent
cytoplasmic (stathmin, MAP1b, MAP2) and nuclear (e.g., ATF2,
ELK1, p53, etc.) targets (Björkblom et al., 2005; Bogoyevitch and
Kobe, 2006; Barnat et al., 2010; Westerlund et al., 2011), points to
a possible parting of ways: i.e., the observed JNK null effects on
regeneration are c-Jun independent, and the strong Jun-dependent
effects on regeneration and survival do not require N-terminal
phosphorylation. Recent studies using Jun4A mice where all four
JNK dependent N-terminal phosphorylation sites – Thr91 and 93
as well as Ser63 and 73 – are removed (Patodia et al., unpublished
observations) partially conﬁrm this notion. The Jun4A mutation
does not interfere with the expression of injury-associated neu-
ronal and non-neuronal markers. On the other hand, as in the
JNK1 and 3 null mutants, the Jun4A strain reproduces the mod-
erate reduction in functional recovery and a 40% lower number
of reinnervating motoneurons at 28 days following facial nerve
cut. However, this effect on regeneration is considerably smaller
than that observed for neuronal c-Jun deletion, suggesting that
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the regeneration effect of c-Jun is mostly independent of its N-
terminal phosphorylation. At present, no information is available
with regards to the regeneration-associated Jun effects of Thr239
dephosphorylation, or for C-terminal acetylation.
ACTIVATING TRANSCRIPTION FACTOR 3
Activating transcription factor 3 is a member of the ATF/CREB
family of basic leucine zipper domain (bZIP) transcription factors.
It can form homo- or hetero-dimers with other bZIP transcrip-
tion factors like members of the AP-1 family (ATF2, JunB, JunD,
c-Jun, c-fos) and c/EBPs (Hai andCurran, 1991;Hai andHartman,
2001). ATF3 is normally expressed at low levels, but is rapidly
activated in sensory, sympathetic, and motor neurons by stress
stimuli after peripheral nerve injury (Tsujino et al., 2000; Raivich
and Behrens, 2006; Hyatt Sachs et al., 2007; Zigmond and Vac-
cariello, 2007), optic nerve injury (Takeda et al., 2000), and NGF
depletion (Mayumi-Matsuda et al., 1999) but not after central
injury (Tsujino et al., 2000). ATF3 expression is also induced in
the disconnected Schwann cells and endoneurial ﬁbroblasts distal
to the peripheral injury site, though not on central, denervated glia
(Hunt et al., 2004). Several pathways have been implicated in acti-
vating ATF3 expression such as neurotrophin deprivation (Hyatt
Sachs et al., 2007), as well as JNK/SAPK and p53-dependent mech-
anisms (Moore and Goldberg, 2011). ATF3 is axonally transported
from the periphery (Lindwall and Kanje, 2005), possibly acting as
a retrograde signal.
Delivery of ATF3 to adult DRG neurons, neonatal SCG neurons
and PC12 cells, enhanced both the number of neurons extend-
ing neurites and neurite length (Nakagomi et al., 2003; Pearson
et al., 2003; Seijffers et al., 2006). As after conditioning peripheral
injury, the pattern of growth consisted of long neurites rather than
branched arborized ones (Seijffers et al., 2007). In transgenic mice
constitutively expressing ATF3 in adult DRGs, the rate of periph-
eral nerve regeneration (measured by the nerve pinch test 2 days
after sciatic nerve crush) was enhanced to an extent comparable to
that produced by a preconditioning lesion (Seijffers et al., 2007).
The expression of some growth-associated genes, such as Hsp27,
SPRR1A, and c-Jun was increased in the non-injured neurons,
but not of others like the alpha 7 integrin subunit (α7), GAP-
43, CAP23, and STAT3. Unlike peripheral nerve-conditioning
lesions, ATF3 overexpression also did not overcome the inhibi-
tion produced by CNS myelin in culture, suggesting the mecha-
nisms responsible for axonal regeneration are separate from those
involved in overcoming glial-associated inhibition (Seijffers et al.,
2007).
Activating transcription factor 3 can bind directly to the Hsp27
promoter and activate its expression inPC12 cells (Nakagomi et al.,
2003). In addition to its role as an injury-induced neuronal sur-
vival factor, Hsp27 enhances neurite outgrowth in cultured adult
DRGneurons (Williams et al., 2006), possibly as a result of interac-
tions with the cytoskeleton. The growth-associated gene SPRR1A
promotes axonal outgrowth by interacting with actin structures
(Bonilla et al., 2002) andATF3may regulate its expression either by
binding directly to its promoter or by affecting other transcription
factors. ATF3 also appears to have a survival role, preventing JNK-
mediated neuronal death (Nakagomi et al., 2003). Thus, although
ATF3 appears to contribute to nerve regeneration by increasing
the intrinsic growth state of injured neurons, its upregulation is
not enough to fully recapitulate the peripheral nerve regeneration
program (Seijffers et al., 2007).
Activating transcription factor 3 can form hetero-dimers with
c-Jun, leading to enhanced transcriptional activation of various
RAGs and increased neurite outgrowth in neuronal cell lines (Hai
and Curran, 1991; Hai and Hartman, 2001; Pearson et al., 2003).
There has been a number of conﬂicting reports regarding the cor-
relation between increased ATF3 expression and upregulation of
c-Jun in surviving neurons. In 2003, Pearson et al., showed that
in the absence of c-Jun, ATF3 failed to enhance neurite outgrowth
in PC12 cells, suggesting that a coincident presence of c-Jun and
ATF3may act synergistically (possibly via a physical interaction) to
promote nerve regeneration (Pearson et al., 2003; Lindwall et al.,
2004). In contrast, Seijffers et al. (2006) showed enhanced neurite
outgrowth in adult DRG neurons by ATF3 without any increase
in endogenous c-Jun levels. The scope of c-Jun and ATF3 expres-
sion in DRG neurons after sciatic nerve transection also differs:
ATF3 is induced in all injured neurons, phosphorylated c-Jun only
in a small subset of mostly small and medium sized DRG neu-
rons (Kenney and Kocsis, 1998; Tsujino et al., 2000; Lindwall et al.,
2004). Sciatic nerve injury induces prolonged activation of JNKs
in the DRGs (Kenney and Kocsis, 1998). Inhibiting JNK in this
model led to decreased activation of c-Jun and ATF3 expression,
and to decreased axonal growth (Lindwall et al., 2004). Recent
results from our group show that deletion of neuronal c-Jun or
STAT3 interferes with the nuclear transfer of ATF3 in the axo-
tomized facial motor neurons (Patodia and Raivich, unpublished).
This effect may be speciﬁc for motoneurons – in sympathetic neu-
rons, cell-speciﬁc deletion of gp130 interferes with the appearance
of phosphorylated nuclear STAT3, but does not affect the nuclear
translocation of ATF3 (Habecker et al., 2009). Thus, the extent to
which the growth promoting action of ATF3 is autonomous of c-
Jun and STAT3 and dependent on additional injury signals needs
to be explored.
cAMP RESPONSE ELEMENT BINDING PROTEIN
TheCREB is amember of theATF/CREB family of bZIP transcrip-
tion factors (Hai and Hartman, 2001), and mediates cAMP signal-
ing in the nervous system by forming homo- or hetero-dimers
with other bZIP factors (Hannila and Filbin, 2008). The brains
of CREB null mice show abnormal development of the corpus
callosum and anterior commissure (Rudolph et al., 1998). CREB
can be phosphorylated and activated by many kinases, including
PKA, PKC, CAMKII, CAMKIV, AKT, MAPKAP K2, and members
of RSK and MSK families (Mayr and Montminy, 2001), and it is
negatively regulated by phosphatases such as PP1 and PP2A (Sun
et al., 1994). Important targets of CREB include arginase I and
BDNF (Mayr and Montminy, 2001; Cai et al., 2002; Deng et al.,
2009).
In vitro cultured DRG and SCG neurons from CREB null mice
show shorter neurites than controls. In vivo, these mutant mice
exhibit impaired axonal growth and projections. Their sensory
neurons undergo excess apoptosis and degeneration during the
period of NGF dependency in the absence of CREB (Lonze and
Ginty, 2002; Lonze et al., 2002). In addition, overexpression of a
dominant negative CREB leads to decreased dendritic outgrowth
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in cortical neurons and loss of cAMP or neurotrophin associated
neurite outgrowth on an inhibitory substrate (Redmond et al.,
2002). This suggests an important role for CREB-mediated gene
expression for both survival and axonal growth in PNS neurons.
Recently, it has been suggested that axonal translation of CREB
mRNAs may precede its phosphorylation, nuclear translocation,
and transcriptional activation of pro-survival genes (Cox et al.,
2008).
SIGNAL TRANSDUCER AND ACTIVATOR OF
TRANSCRIPTION-3
Signal transducer and activator of transcription-3 belongs to the
STAT family of seven transcription factors – STAT1,STAT2,STAT3,
STAT4, STAT5a, STAT5b, and STAT6 – that mediate a wide vari-
ety of biological functions in the CNS and PNS such as cell
growth, regulation, inﬂammation, and embryological develop-
ment (Dziennis and Alkayed, 2008). The STATs are comprised
of six regular domains – an amino terminal (for STAT3 dimer-
ization after activation), coiled-coil domain (for interaction with
other transcription factors and regulatory proteins),DNA binding
domainmade up of β-sheets (for recognition of consensus binding
regions on gene promoters), α-helical linker domain (for tran-
scriptional activation and protein–protein interaction), a classical
SH2 (sequence – homology) docking domain, and a transcrip-
tional activation domain (Bromberg and Darnell, 2000; Lim and
Cao, 2006). There are two highly conserved, phosphorylatable
amino acids that are frequently required for STAT3 activation – a
tyrosine 705 in the SH2 domain and a serine 727 in the 78-amino
acid region of the transactivation domain (Bromberg and Darnell,
2000; Dziennis and Alkayed, 2008).
Injury-induced ligand binding to cell-surface receptors acti-
vates the associated receptor tyrosine kinase Janus kinases (JAKs),
which phosphorylate tyrosine residues on the cytoplasmic por-
tion of the receptor complex that acts as a binding site for
STAT proteins. STATs dock onto the phospho-tyrosines via their
SH2 domain, and are also phosphorylated by JAK on a tyrosine
residue (e.g.,Y705 in STAT3). Upon activation, they either hetero-
or homodimerize and translocate to the nucleus via importins
(Cimica et al., 2011), where they bind to consensus sequences
(SIE/GAS/ISRE sequences) to induce gene transcription. Other
mechanisms of STAT activation include phosphorylation by non-
receptor tyrosine kinases such as Src,direct,or indirect phosphory-
lation by receptors with intrinsic tyrosine kinase activity (i.e., EGF,
PDGF, and FGF receptors), and activation by G-protein coupled
receptors (Ram and Iyengar, 2001). STAT3 can be deactivated by
dephosphorylation or targeted degradation, and recycled back to
the cytosol (reviewed by Lim and Cao, 2006; Dziennis and Alka-
yed, 2008; Moore and Goldberg, 2011). Further, Suppressor of
Cytokine Signaling 3 (SOCS3) or protein inhibitors of activated
STATS (PIAS) can also inhibit STAT3 activation (Krebs andHilton,
2001).
In the adult brain, STATs are normally quiescent, but are acti-
vated following injury in response to multiple signaling path-
ways induced by several cytokines and growth factors includ-
ing IL-6, LIF, CNTF, G-CSF, G-CSFR, EPO, EGF, IGF-1, NGF
withdrawal, BDNF, free radicals, excitatory neurotransmitters
and other inﬂammatory mediators that are released after injury
(reviewed in Dziennis and Alkayed, 2008). Propagation of many
of these signals (IL-6, LIF, and CNTF) requires a combination of
various ligand binding units and a common signal-transducing
unit gp130 (Taga and Kishimoto, 1995), through which they
activate the JAK/STAT, Ras/MAPK, extracellular regulated-signal
kinase (ERK), PI3K, and other pathways (Akira, 2000; Heinrich
et al., 2003). Activation of the gp130-receptor has been implicated
in neuronal response to injury and regenerative axonal growth
(Habecker et al., 2009; Hyatt Sachs et al., 2010).
Signal transducer and activator of transcription-3 was identi-
ﬁed as an acute phase response factor (Akira et al., 1994) and is
expressed cytoplasmically in both neuronal and glial cells during
development and in the adult (De-Fraja et al., 1998; Gautron et al.,
2006). Nervous system insult leads to STAT3 activation in speciﬁc
subsets of neurons with the pattern of activation dependent on the
nature of the insult (Schwaiger et al., 2000; Xia et al., 2002). Global
STAT3 knockout animals are embryonic lethal, dying prior to gas-
trulation between E6.5 and 7.5 (Takeda et al., 1997). Cell-type
speciﬁc STAT3 deletion has greatly improved our knowledge of
its function in different tissues (Sauer, 1998; Akira, 2000). STAT3
deletion in T-cells is associated with impaired T-cell proliferation,
in macrophages with high susceptibility to endotoxin shock, in
keratinocytes with compromised wound healing process, and in
mammary glands with delay of involution (Akira, 2000). Nestin-
promoter mediated neural-speciﬁc disruption of STAT3 resulted
inmicewhichwere hyperphagic,obese,diabetic, and infertile (Gao
et al., 2004).
In the last decade, there has been growing evidence of a role
of STAT3 in axonal regeneration. In vitro, STAT3 induces neu-
rite growth in motor and sensory neurons and this growth can be
inhibited by the application of SOCS3 (Liu and Snider, 2001;Miao
et al., 2006). STAT3 induces GAP-43, a protein found in growth
cones, and GAP-43 expression is inhibited with the JAK inhibitor
AG-490, suggesting a role for the JAK/STAT3 pathway in GAP-
43 expression and neurite outgrowth and regeneration (Wu and
Bradshaw, 1996).
Haas et al. (1999) observed STAT3 activation at 24 h and
5 days after rat facial nerve axotomy. Following rat facial and
hypoglossal nerve axotomy, a transient but signiﬁcant increase
in STAT3 mRNA, along with its phosphorylation and nuclear
translocation within 3 h in neurons and 1 day in astrocytes was
observed by Schwaiger et al. (2000). In contrast, these changeswere
not observed in non-regenerating neurons of Clarke’s nucleus,
although both forms of injury upregulated c-Jun and GAP-43
expression (Schwaiger et al., 2000). Transient increases in STAT3
signaling were also found in sprouting neurites and astrocytes
following entorhinal cortex lesions in addition to a rise in gp130-
receptor cytokines, suggesting a dual role of STAT3 in both astro-
cytic regulation and axonal sprouting (Xia et al., 2002). Lee et al.
(2004) showed that axonal STAT3, activated at the injury site, acts
as both a retrograde injury signal and as a transcription factor
which promotes the survival and regeneration of both sensory
and motor neurons. Levels of activated STAT3 increased in the
nuclei of regenerating adult cranial motor neurons, sciatic motor
neurons and in sensory neuron nuclei after injury. Sciatic nerve
lesion led to a very rapid activation of STAT3 in axons at the lesion
site within 15min, and by 24 h STAT3 labeling was detected in
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the DRG and in the spinal cord (Lee et al., 2004). These levels of
STAT3 decreased when regeneration was completed, emphasizing
its role in the regenerative process.
Deletion of CNTF, which is abundantly present in myelinating
Schwann cells but not in or around the cell bodies of axotomized
motoneurons (Dobrea et al., 1992; Rende et al., 1992) caused a
delay in the appearance of phosphorylated STAT3 and its nuclear
translocation in neuronal cell bodies (Kirsch et al., 2003). This
delay points to a signaling cascade beginning with local release
of CNTF by damaged myelinating Schwann cells, its local action
on adjacent axons, intra-axonal phosphorylation of STAT3 and
its retrograde transport to the cell bodies of injured neurons and
ﬁnally to the nucleus. Recent studies using repetitive in vivo imag-
ing of individual ﬂuorescently labeled axons have shown that
STAT3 selectively regulates initiation but not later perpetuation
of axonal growth, thus acting as a phase-speciﬁc regulator of
axonal outgrowth in both PNS and CNS (Bareyre et al., 2011).
Altogether, these studies show a general trend of early and persis-
tent expression of phosphorylated STAT3 during the regenerative
process.
A number of in vitro and in vivo studies have also implicated
the role of STAT3 as an intracellular survival-promoting factor.
In vitro studies using cell lines have shown that STAT3 expression
directly induces bcl-2 and bcl-xL gene expression,which are critical
in promoting neuronal survival after injury (Dziennis and Alka-
yed, 2008). Mice lacking STAT3 in facial and spinal motoneurons
(controlled by cre expression under NF-L promoter) showed a sig-
niﬁcant reduction in motoneuron survival after facial nerve lesion,
which closely correlated with the extent of motoneuron loss seen
in LIF/CNTF KO mice after nerve lesion (Sendtner et al., 1996;
Schweizer et al., 2002). Moreover, upregulation of Reg-2 and Bcl-
xl expression was reduced in axotomized motoneurons in STAT3
KO mice, suggesting a role of STAT3 in anti-apoptotic signaling.
Interestingly, in the study by Schweizer et al. (2002) local appli-
cation of CNTF strongly reduced the apparent motoneuron cell
death in the absence of neuronal STAT3, but which other signaling
pathways were involved is unclear.
Preliminary data from our lab suggests an important role for
neuronal STAT3 in axonal regeneration (Patodia et al., 2011).
Conditional mice mutants, lacking STAT3 in their neurons, had
profound defects in the usual retrograde response, with a severe
early and persistent reduction by 75–90% in microglial activation
and recruitment of lymphocytes, and 4 days after injury in speed
of axonal elongation in the distal stump. At 30 days, axotomized
STAT3-deﬁcient motoneurons appeared shrunk by 50–60% in
size but displayed no cell death in contrast to results published
earlier (Schweizer et al., 2002). Functional recovery was dramat-
ically reduced and the mutants showed 80% less target muscle
re-innervation. As with neuronal c-Jun deletion which interferes
with regeneration (Raivich et al., 2004), expression of RAGs like
CD44, β1 integrin, CGRP, galanin as well as the nuclear translo-
cation of ATF3 was also greatly diminished or abolished in the
STAT3 mutants. However, c-Jun expression itself was not affected,
suggesting that deletion of either transcription factor – c-Jun
or STAT3 – will produce a very similar regeneration-deﬁcient
phenotype.
CCAAT/ENHANCER BINDING PROTEIN β, δ
The C/EBP family of transcription factors is comprised of six pro-
teins (C/EBPα, β, γ, δ, ε, and ζ), each having unique properties
regulating cellular proliferation and differentiation, particularly
in hepatocytes, adipocytes, and hematopoietic cells (Ramji and
Foka, 2002). C/EBPs also play pivotal, non-redundant roles in the
development and plasticity of the nervous system, including cell
fate determination, apoptosis, synthesis and response to trophic
factors and responses to brain injury and ischemia (Kfoury and
Kapatos, 2009). All members have a DNA binding domain and
a highly homologous bZIP domain which is required for dimer-
ization. The C/EBPs can interact with other bZIP and non-bZIP
transcription factors (Huang et al., 2007).
CCAAT/enhancer binding protein-δ (also known as CELF,
CRP3, and NF/IL-6) expression is typically low to undetectable
in most cell-types and tissues, but it is rapidly induced by a vari-
ety of extracellular stimuli (e.g., growth hormone, insulin, IFNγ,
IL-1, IL-6, LPS, TNFα, noradrenaline, and glutamate), phospho-
rylated, and translocated to the nucleus as an active transcription
factor where is induces further IL-6 expression (Ramji and Foka,
2002). The most favorable complex responsible for the transcrip-
tion of the IL-6 gene requires the interaction between p65 and
C/EBPδ, with c-Jun occurring on the NF-κB site (Faggioli et al.,
2004). C/EBPδ is elevated in hypoxia, glaucoma, carcinoma, trau-
matic brain injury and in the brains of Alzheimer’s disease patients
(Huang et al., 2007; Yang et al., 2007). A recent study showed that
the anti-inﬂammatory and neuroprotective effects of chrysin on
reactive microglial cell induced neurotoxicity was partly medi-
ated by inhibition of C/EBPδ expression at both protein and
mRNA levels. C/EBPδ-deﬁcient microglial cultures produce less
NO and TNFα in response to LPS/IFNγ, re-afﬁrming its role
in microglial activation and neuroinﬂammation (Gresa-Arribas
et al., 2010). C/EBPβδ double knockout in mouse embryonic
ﬁbroblasts showed particularly impaired production of IL-6 and
TNFα in response to LPS or IL-1, suggesting complementary
roles of C/EBPβ and C/EBPδ in induction of proinﬂammatory
cytokines (Ramji and Foka, 2002).
CCAAT/enhancer binding protein β is upregulated and phos-
phorylated across different classes of injured neurons, including
the invertebrate Aplysia model. In this model, phosphorylation of
Aplysia C/EBPβ is mediated by the RISK1, a mitogen associated
protein kinase homolog related to the ERK family (Sung et al.,
2001). In the mouse facial nerve model, C/EBPβ is important
for the expression of regeneration-associated microtubule Tα1 α
tubulin and growth cone protein GAP-43, suggesting that C/EBPβ
is a critical component of the regenerative response (Nadeau et al.,
2005).
In the case of C/EPBδ, which is upregulated in sensory and
sympathetic neurons (Boeshore et al., 2004; Magoulas and Lopez-
de Heredia, 2010), initial studies using cultured primary sensory
neurons from C/EPBδ null mice show impaired axonal growth
and a reduced response to the conditioning lesion (Magoulas and
Lopez-de Heredia, 2010). Preliminary results from our studies also
conﬁrm this ﬁnding in the motor, facial nerve injury model as well
as indicate a role for C/EBPδ in early and late microglial activation
(Patodia et al., unpublished).
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In summary, a number of intriguing ﬁndings implicate a role
of C/EBPs in injury response in neurons, i.e., they are mediators of
neuro-inﬂammatory responses in the brain; are induced in injured
neurons of invertebrates (Korneev et al., 1997; Sung et al., 2001)
as well as vertebrates (Nadeau et al., 2005); have RAGs like Tα1
α tubulin and GAP-43 as direct transcriptional targets (Nadeau
et al., 2005); and are upregulated by IL-6, an important post-injury
molecule (Ramji et al., 1993). A number of alternative signaling
pathways might also converge onto C/EBP family members fol-
lowing axonal injury, e.g., the JAK–STAT pathway has been shown
to directly regulate C/EBPβ (Jiang and Zarnegar, 1997).
Oct-6
Transcription factors Oct-6 (SCIP/Tst-1), Krox-20 (Egr-2), and
Sox 10 are major regulators of Schwann cell differentiation and
myelination (Topilko et al., 1994; Bermingham et al., 1996; Jaegle
and Meijer, 1998). A fragment distal to the Oct-6 gene, con-
taining two DNase I-hypersensitive sites, acts as the Schwann
cell-speciﬁc enhancer (SCE) and is responsible for the complex
signaling between Schwann cells and axons driving myelination,
during both normal peripheral nerve development and regenera-
tion (Mandemakers et al., 2000). Oct-6 is present in the cytoplasm
of Schwann cells associated with myelinated ﬁbers of intact nerves.
Axonal injury induces nuclear Oct-6 expression during the acute
degenerative stage, reaching peak expression levels in the subse-
quent regenerative stage (Scherer et al., 1994;Kawasaki et al., 2003),
suggesting that at the time of regeneration, Oct-6 is translocated
to the nucleus to promote transcription of genes, possibly those
encoding myelin proteins. Oct-6 expression is down-regulated in
fully regenerated nerves and in nerves showing chronic axonal
loss (Kawasaki et al., 2003). Therefore, Oct-6 may be a marker
for dedifferentiation of adult Schwann cells and active nerve
regeneration.
Sox11
SRY-box containing gene 11 (Sox11), a member of the Sox tran-
scription factor family, is highly expressed in developing sensory
neurons and at low levels in adult neurons (Jankowski et al., 2006;
Moore andGoldberg, 2011). There has been limited study of Sox11
targets in axonal growth, but Sox11 can partner with Brn1 or -2 to
regulate transcription (Kuhlbrodt et al., 1998; Tanaka et al., 2004)
and drive expression of neurite growth-associated genes like β-III
tubulin, MAP2 (Bergsland et al., 2006) and actin-related protein
complex 3 (Arpc3; Jankowski et al., 2006). Sox11 expression in
sensory and sympathetic ganglia is highly sensitive to nerve cut
and crush injuries, rising steadily after injury and during subse-
quent regeneration, and returning to baseline levels at the end of
regeneration (Boeshore et al., 2004; Jankowski et al., 2006, 2009).
In Neuro2a cells, Sox11 levels dramatically increased with the
number of cells extending neurites. In vitro experiments using
cultured adult DRG neurons treated with Sox11 siRNAs exhibit
a signiﬁcant decrease in regeneration following axotomy as indi-
cated by reduced neurite length and branching index (Jankowski
et al., 2006). This suggests a correlation between Sox11 and neurite
growth.
Injection of Sox11 siRNAs into mouse saphenous nerve caused
a transient knockdown of Sox11 mRNA, that transiently inhibited
in vivo regeneration after nerve crush. Electron microscopy analy-
sis of Sox11 RNAi-injected nerves showed that regeneration of
both myelinated and unmyelinated axons was inhibited. Nearly
all neurons in the ganglia of crushed nerves that were Sox11
immunopositive showed co-labeling for ATF3 (Jankowski et al.,
2009) and treatment with Sox11 siRNAs in vitro and in vivo caused
a transcriptional and translational level reduction in ATF3 expres-
sion. Interestingly,ATF3 ablation usingATF3 siRNAs did not affect
Sox11 levels, suggesting that Sox11 may act upstream of ATF3 and
inﬂuence regulation of its gene expression (Jankowski et al., 2009).
These anatomical and expression data support an intrinsic role for
Sox11 in axonal regeneration that may involve interaction with
ATF3.
p53
p53 is a member of a family of tumor suppressors together with
p63 and p73. Like c-Jun, p53 is known to mediate both pro- and
anti-apoptotic roles in the nervous system (Culmsee and Matt-
son, 2005; Jacobs et al., 2006). p53 can undergo multiple types of
post-translational modiﬁcations including acetylation, phospho-
rylation, and ubiquitination, which can affect its localization and
function (Lavin and Gueven, 2006; Tedeschi et al., 2009). In vitro
and in vivo experiments have shown that p53 plays a role in pro-
moting neurite growth. Overexpression of a dominant negative
form of p53 in primary cortical neurons leads to growth cone
collapse and decrease in neurite outgrowth, possibly due to a
combination of reduced expression of its growth cone associated
target genes Coronin1b, Rab13, and GAP-43 (Di Giovanni et al.,
2006; Tedeschi et al., 2009), as well as its local, non-transcriptional
activity at the growth cone (Qin et al., 2009). On the other hand,
overexpression of wild-type p53 leads to an increase in growth
cone size (Qin et al., 2009). Other axonal guidance molecules and
their receptors like netrins, semaphorins, and ephrins are also reg-
ulated by p53 (Arakawa, 2005). In vivo experiments using p53
knockout mice showed a signiﬁcant decrease in the number of
ﬁbers reinnervating the target muscles at 28 days after facial axo-
tomy in themutantmice when comparedwith control animals (Di
Giovanni et al., 2006). Taken together, these studies suggest a role
for p53 in modulating neurite growth and regeneration. Given its
well described role in apoptosis of neurons andnon-neuronal cells,
it will be interesting to investigate its effects on neuronal survival
after peripheral nerve injury.
NUCLEAR FACTOR KAPPA-LIGHT-CHAIN-ENHANCER OF
ACTIVATED B CELLS
Nuclear factor kappa-light-chain-enhancer of activated B cells is
an inducible transcription factor dimer made up of 5 subunits,
bound as homo- or hetero-dimers: RelA/p65, c-Rel, RelB, p50, and
p52. Inhibitor of κB (Iκβ) family of proteins can bind to NF-κB
dimer and prevent its nuclear translocation. Dissociation or pro-
teasomal degradation of IκB reveals NF-κB’s nuclear localization
sequence (NLS), allowing it to move to the nucleus and mod-
ulate gene transcription by binding to promoter and enhancer
sequences (reviewed by Moore and Goldberg, 2011).
Nuclear factor kappa-light-chain-enhancer of activated B cells
is signiﬁcantly upregulated in DRGs and spinal cord after periph-
eral nerve crush (Ma and Bisby, 1998; Pollock et al., 2005). It can
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respond to a stimulus in neurites and retrogradely travel to the
nucleus to affect gene transcription. NF-κB signaling can either
enhance of inhibit neurite growth depending on the phosphory-
lation status of its RelA/p65 subunit. Phosphorylation of p65 by
IKKβ results in reduced neurite growth, and in neurons without
this IKKβ activity, there is increased neurite growth (Gutierrez
et al., 2008). Identiﬁed neuronal targets of NF-κB include genes
for Bcl-2, MnSOD, glutamate receptor subunits, BDNF, and cal-
cium regulating proteins (reviewed byMattson,2005). In addition,
NF-κB has been shown to regulate expression of cell-adhesion
molecules like NCAM, tenascin C and β1 integrin in other systems
(reviewed by Moore and Goldberg, 2011). NF-κB is also the down-
stream modulator of neurite growth for fas apoptosis inhibitory
molecule (FAIM) signaling. Blocking NF-κB activation prevents
the increase of neurite growth seen with FAIM overexpression
(Sole et al., 2004).
ELK
The ETS-like (ELK) subfamily of transcription factors comprises
of ELK1, ELK3, and ELK4 factors which can have different poten-
tial protein–protein interactions, and respond differently to MAP
kinase signaling pathways (Ducret et al., 2000; Buchwalter et al.,
2004). Seven days after peripheral axotomy, a 2.3-fold upregu-
lation of ELK3 mRNA, but not of ELK1 or ELK4 mRNA was
detected in adult mouse DRGs (Kerr et al., 2010). The expression
of neuropeptide galanin mRNA is upregulated around 80-fold
in DRGs following axotomy, and an 18 bp sequence within its
promoter/enhancer region containing overlapping putative ETS,
STAT, and Smad binding sites, has been shown to be critical for
this response (Bacon et al., 2007), making ELK3 a potentially
important player in peripheral nerve regeneration. It would be
interesting to see if the injury-induced ELK3 isoforms can dif-
ferently affect neuronal survival and/or regeneration after axonal
injury.
CROSS-TALK BETWEEN TRANSCRIPTION FACTORS
Transcription factors forman intricate network inwhich cross-talk
between different pathways leads to an integrated and input-
balanced signaling outcome (Morrison and Davis, 2003; Moore
and Goldberg, 2011). Some axonal regeneration still occurs in the
absence of master regulators of regeneration like c-Jun, highlight-
ing the existence of alternative pathways, and of compensatory and
complementary/synergistic mechanisms, which may be shared
during axonal outgrowth.
Jun N-terminal kinase signaling is interconnected with various
other cellular signaling pathways, such as NFkB and the JAK/STAT
system (Waetzig et al., 2006; Haeusgen et al., 2009), resulting in
STAT3 phosphorylation (Levy and Lee, 2002). Besides JNK, c-Jun
can also be activated by ERK1/2 (Leppa et al., 1998; Schwarz et al.,
2002; Morton et al., 2003). On the other hand, STAT3 can stimu-
late transcription of several AP-1 members including JunB (Coffer
et al., 1995) and c-fos (Yang et al., 2003; Higashi et al., 2004) which
have STAT3 responsive elements in their regulatory sequence.
The interactions between AP-1 and STAT3 are multiple and
complex, resulting in mutual modulation of their transcriptional
activities. STAT3 and AP-1 factors can bind to independent but
closely spaced DNA binding sites in the regulatory sequences of
a number of genes, such as α-2 macroglobulin (Schaefer et al.,
1995), VIP (Symes et al., 1997), bcl-6 (Arguni et al., 2006), and
matrix metallo-proteinases and synergistically induce maximal
enhancer function (Zhang et al., 1999). AP-1 complexes can also
bind directly to STAT3, enhancing STAT3’s transcriptional activity
(Schaefer et al., 1995; Leu et al., 2001). Mapping of the STAT3–c-
Jun interactive regions by GST pull-down assays suggested that the
STAT3-interactive region lies within its coiled-coiled domain, and
in a portion of the DNA binding domain. The c-Jun interactive
region was within its C-terminal residues 105–334. Point muta-
tions within these regions blocked their interaction (Zhang et al.,
1999). SOCS3 was discovered for its ability to inhibit tyrosine
phosphorylation of STAT3 through binding to gp130 and JAKs
(Krebs and Hilton, 2001). It has subsequently been shown that
endogenous SOCS3 can also inhibit AP-1 activity by blocking JNK
phosphorylation (Miao et al., 2008). Therefore SOCS3 could be an
important molecule regulating axonal regeneration by controlling
changes in JNK and JAK/STAT signaling pathways after injury.
Additional transcription factors encompassing a compen-
satory/complementary role include the C/EBP family members
C/EBPβ and C/EBPδ. The promoter region of a c-Jun coactivator,
an oncogene Jab1, contains binding sequences for C/EBP, GATA,
as well as a STAT3 consensus sequence overlapping the C/EBP
site. Both, mutation of the C/EBP binding site and inhibition of
STAT3, signiﬁcantly reduced Jab1-promoter activity (Shackleford
et al., 2011). C/EBPβ is essential for appropriate induction and
maintenance of GAP-43 mRNA following axonal injury (Nadeau
et al., 2005). While there is no evidence of a direct binding site for
C/EBP on the GAP-43 gene, it contains a functionally important
AP-1 site for c-Jun and c-fos (Weber and Skene, 1998). C/EBPβ can
bind to and regulate both c-fos and c-Jun (Nadeau et al., 2005),
suggesting a coordinated induction of GAP-43 by C/EBPβ, c-fos,
and c-Jun in injured neurons. It has already been shown that co-
expression of c-Fos with c-Jun induces a greater number of cells
to produce neurites than c-Jun alone (Leppa et al., 1998).
We have already discussed a number of different studies investi-
gating the complex associationbetweenATF3 and c-Jun expression
after injury. Besides interacting with leucine zipper transcription
factors, ATF3 can also interact with other transcription factors
upregulated after peripheral injury, such as, STAT3. This could
be via co-activators or by synergistic binding to adjacent DNA
binding sites. For example, SPRR1A, a target gene for ATF3, is a
gp130 pathway protein and its promoter region contains func-
tional AP-1 binding sites (Sark et al., 1998; Pradervand et al.,
2004). The levels of SPRR1A expression in DRGs of injured
wild-type mice are higher than in DRGs of non-injured trans-
genic mice expressing constitutively active ATF3, suggesting that
other downstream signals in addition to ATF3 are likely to govern
SPRR1A expression. C/EBPβ, for example, is induced after periph-
eral nerve injury (Nadeau et al., 2005) and a functional C/EBPβ
binding site is located on the SPRR1Apromoter (Pradervand et al.,
2004).Recently, transcriptionof DINE (damage-inducedneuronal
endopeptidase), an enzyme involved in terminal nerve branching
(Nagata et al., 2010), was shown to be increased 60-fold by Sp1
mediated recruitment of STAT3, c-Jun, and ATF3 to the DINE
promoter in response to LIF upregulation and NGF withdrawal
following injury (Kiryu-Seo et al., 2008).
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Nuclear factor kappa-light-chain-enhancer of activated B cell
can also interact with Jun, ATF, CREB, and Fos transcription fac-
tors. STAT3 can induce the alternative NF-κB pathway, and bind
to DNA in a complex with p52, to induce transcription. p53 can
also interact with p52 to regulate expression of its target genes
(reviewed by Perkins, 2007).
Mathematical models of interacting signaling pathways have
been developed to predict regenerative outcomes after injury
(Moya et al., 2011).Transgenic animal models with deletion of
multiple signaling streams will be very useful in identiﬁcation of
functional complementary counterparts.
DOWNSTREAM TARGETS OF TRANSCRIPTION FACTORS
Transcription factors rapidly condition the injured nerve and
within 1–4 days after injury, the neuronal perikaryon produces a
plethora of RNA, protein, and glycolipid components which play a
vital role in executing axonal regeneration. Downstream targets of
the transcription factors include a vast number of RAGs that may
be involved in cell–cell signaling, axonal growth and sprouting, and
activation of the non-neuronal, cellular milieu. Successful axonal
regeneration is accompanied by the appearance of functionally
diverse families of molecules that regulate surface cytoskeletal
interaction. Examples of regeneration-associated cytoskeletal fam-
ilies include the GMC family of “integral” membrane proteins –
GAP-43, MARCKS, and CAP23 (Skene and Willard, 1981; Bomze
et al., 2001), microtubule disassembly molecules (e.g., SCG10,
stathmin, CRMP2, and RB3; Iwata et al., 2002; Mori and Morii,
2002), and the Rho GTPase family (RhoA, Rac, Cdc42, and TC10)
members which act as molecular switches regulating cytoskeletal
structure, dynamics, and cell-adhesion (Etienne-Manneville and
Hall, 2002). Regenerating neurons also upregulate adhesion mole-
cules like integrinsα7 andβ1 (Kloss et al., 1999),CD44 (Jones et al.,
2000), galectin-1 (Horie and Kadoya, 2000), β2-microglobulin
(Oliveira et al., 2004), ninjurin (Araki and Milbrandt, 2000), and
gicerin/CD146 (Hiroi et al., 2003). Neurotrophins like BDNF and
GDNF are induced in the distal stump of the injured axons,
and their exogenous application promotes axonal regeneration of
chronically injured neurons (Boyd and Gordon, 2003a,b). In vitro
studies have shown that different neuropeptides like substance
P, somatostatin, vasopressin, calcitonin, and alpha-MSH exert a
moderate but signiﬁcant neurite growth promoting effect on CNS
and PNS neurons (Narumi and Fujita, 1978; Brinton and Gruener,
1987;Raivich, 2011). Transgenic and pharmacological studies have
conﬁrmed a similar role in vivo for peptides like galanin (Holmes
et al., 2000; Wynick et al., 2001), CGRP (Toth et al., 2009), and
PACAP (Pituitary Adenylate Cyclase Activating Peptide; Kimura
et al., 2003; Suarez et al., 2006; Armstrong et al., 2008).
CONCLUDING REMARKS
Injury to peripheral nerves can occur due to several causes rang-
ing from physical injury and accidental trauma to pathological
conditions and degenerative diseases. Achieving successful regen-
eration and synchronized functional recovery following neural
damage is one of the biggest challenges faced by neuroscientists
and clinicians. Transcription factors are master switches control-
ling the expression of multiple gene programs, and orchestrating
complex axon growth and regenerative responses. Blocking tran-
scription using RNA polymerase II inhibitors at an early stage
after injury inhibits the capacity of dissociated neurons to elon-
gate neurites (Smith and Skene, 1997), highlighting their crucial
role in efﬁcient regeneration after nerve injury. In this review, we
have attempted to summarize the roles of a number of different
transcription factors in peripheral nerve regeneration and their
complex web of interactions. An overview of the observed phe-
notypes following global and cell-type speciﬁc deletions is given
in Table 1. Understanding the molecular mechanisms underlying
nerve regeneration via various regeneration-associated molecules
and their signaling components will not only help to enhance the
speed and speciﬁcity of peripheral regeneration but improve the
success of central axonal regeneration, as well.
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